210 studies found for:    "Idiopathic pulmonary fibrosis"
Show Display Options
Rank Status Study
21 Unknown  The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Condition: IDIOPATHIC PULMONARY FIBROSIS
Intervention:
22 Completed First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: GSK3008348 Nebuliser solution;   Drug: Placebo Nebuliser solution;   Radiation: GSK26346763: ([18F]-FBA-A20FMDV2) IV infusion
23 Unknown  Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Behavioral: Pulmonary Rehabilitation
24 Unknown  Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: minocycline
25 Completed Safety and Tolerability Study of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: FG-3019
26 Recruiting Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cotrimoxazole;   Drug: Placebo
27 Completed
Has Results
A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Placental MSC
28 Withdrawn Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Macitentan
29 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
30 Completed Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Drug: Placebo
31 Completed
Has Results
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Bosentan
32 Recruiting Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   IPF
Interventions: Drug: tipelukast;   Drug: Placebo
33 Unknown  Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:
34 Terminated A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis;   Fibrosis;   Interstitial Lung Disease;   Lung Diseases, Interstitial
Interventions: Drug: CC-930;   Other: Placebo
35 Recruiting Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: ART-123;   Drug: Placebo
36 Recruiting A Safety and Tolerability Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Vismodegib
37 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
38 Terminated
Has Results
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Hypertension
Interventions: Drug: Ambrisentan;   Drug: Placebo
39 Completed Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study
Conditions: Idiopathic Pulmonary Fibrosis;   Lung Disease;   Pulmonary Fibrosis
Intervention: Drug: Imatinib Mesylate (Gleevec)
40 Completed Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years